CRISPR and CRISPR-Associated Genes Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Genome Editing
1.2.3 Genetic engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Perspective (2016-2027)
2.2 CRISPR and CRISPR-Associated (Cas) Genes Growth Trends by Regions
2.2.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 CRISPR and CRISPR-Associated (Cas) Genes Historic Market Share by Regions (2016-2021)
2.2.3 CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Regions (2022-2027)
2.3 CRISPR and CRISPR-Associated (Cas) Genes Industry Dynamic
2.3.1 CRISPR and CRISPR-Associated (Cas) Genes Market Trends
2.3.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
2.3.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
2.3.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue
3.1.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (2016-2021)
3.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Players (2016-2021)
3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CRISPR and CRISPR-Associated (Cas) Genes Revenue
3.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio
3.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2020
3.5 CRISPR and CRISPR-Associated (Cas) Genes Key Players Head office and Area Served
3.6 Key Players CRISPR and CRISPR-Associated (Cas) Genes Product Solution and Service
3.7 Date of Enter into CRISPR and CRISPR-Associated (Cas) Genes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Type
4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Type (2016-2021)
4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2022-2027)
5 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Application
5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Application (2016-2021)
5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2016-2027)
6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
6.2.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2016-2021)
6.2.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2022-2027)
6.2.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2016-2027)
6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
6.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2016-2021)
6.3.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2022-2027)
6.3.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2016-2027)
6.4 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
6.4.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2016-2021)
6.4.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size (2016-2027)
7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
7.2.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2016-2021)
7.2.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2022-2027)
7.2.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2016-2027)
7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
7.3.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2016-2021)
7.3.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2022-2027)
7.3.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2016-2027)
7.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
7.4.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2016-2021)
7.4.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size (2016-2027)
8.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
8.2.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2016-2021)
8.2.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2022-2027)
8.2.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2016-2027)
8.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
8.3.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2016-2021)
8.3.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2022-2027)
8.3.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2016-2027)
8.4 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region
8.4.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2016-2021)
8.4.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2016-2027)
9.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
9.2.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2016-2021)
9.2.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2022-2027)
9.2.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2016-2027)
9.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
9.3.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2016-2021)
9.3.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2022-2027)
9.3.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2016-2027)
9.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
9.4.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2016-2021)
9.4.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size (2016-2027)
10.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
10.2.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2016-2021)
10.2.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2022-2027)
10.2.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2016-2027)
10.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
10.3.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2016-2021)
10.3.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2022-2027)
10.3.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2016-2027)
10.4 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
10.4.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2016-2021)
10.4.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.1.4 Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Editas Medicine
11.2.1 Editas Medicine Company Details
11.2.2 Editas Medicine Business Overview
11.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.2.4 Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
11.2.5 Editas Medicine Recent Development
11.3 Caribou Biosciences
11.3.1 Caribou Biosciences Company Details
11.3.2 Caribou Biosciences Business Overview
11.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.3.4 Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
11.3.5 Caribou Biosciences Recent Development
11.4 CRISPR therapeutics
11.4.1 CRISPR therapeutics Company Details
11.4.2 CRISPR therapeutics Business Overview
11.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.4.4 CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
11.4.5 CRISPR therapeutics Recent Development
11.5 Intellia therapeutics, Inc.
11.5.1 Intellia therapeutics, Inc. Company Details
11.5.2 Intellia therapeutics, Inc. Business Overview
11.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.5.4 Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
11.5.5 Intellia therapeutics, Inc. Recent Development
11.6 Cellectis
11.6.1 Cellectis Company Details
11.6.2 Cellectis Business Overview
11.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.6.4 Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
11.6.5 Cellectis Recent Development
11.7 Horizon Discovery Plc
11.7.1 Horizon Discovery Plc Company Details
11.7.2 Horizon Discovery Plc Business Overview
11.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.7.4 Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
11.7.5 Horizon Discovery Plc Recent Development
11.8 Sigma Aldrich
11.8.1 Sigma Aldrich Company Details
11.8.2 Sigma Aldrich Business Overview
11.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.8.4 Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
11.8.5 Sigma Aldrich Recent Development
11.9 Precision Biosciences
11.9.1 Precision Biosciences Company Details
11.9.2 Precision Biosciences Business Overview
11.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.9.4 Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
11.9.5 Precision Biosciences Recent Development
11.10 Genscript
11.10.1 Genscript Company Details
11.10.2 Genscript Business Overview
11.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.10.4 Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
11.10.5 Genscript Recent Development
11.11 Sangamo Biosciences Inc.
11.11.1 Sangamo Biosciences Inc. Company Details
11.11.2 Sangamo Biosciences Inc. Business Overview
11.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.11.4 Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
11.11.5 Sangamo Biosciences Inc. Recent Development
11.12 Lonza Group Limited
11.12.1 Lonza Group Limited Company Details
11.12.2 Lonza Group Limited Business Overview
11.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.12.4 Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
11.12.5 Lonza Group Limited Recent Development
11.13 Integrated DNA Technologies
11.13.1 Integrated DNA Technologies Company Details
11.13.2 Integrated DNA Technologies Business Overview
11.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.13.4 Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
11.13.5 Integrated DNA Technologies Recent Development
11.14 New England Biolabs
11.14.1 New England Biolabs Company Details
11.14.2 New England Biolabs Business Overview
11.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.14.4 New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
11.14.5 New England Biolabs Recent Development
11.15 Origene Technologies
11.15.1 Origene Technologies Company Details
11.15.2 Origene Technologies Business Overview
11.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.15.4 Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
11.15.5 Origene Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Genome Editing
Table 3. Key Players of Genetic engineering
Table 4. Key Players of gRNA Database/Gene Librar
Table 5. Key Players of CRISPR Plasmid
Table 6. Key Players of Human Stem Cells
Table 7. Key Players of Genetically Modified Organisms/Crops
Table 8. Key Players of Cell Line Engineering
Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Regions (2016-2021)
Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Regions (2022-2027)
Table 15. CRISPR and CRISPR-Associated (Cas) Genes Market Trends
Table 16. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
Table 17. CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
Table 18. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
Table 19. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players (2016-2021)
Table 21. Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2020)
Table 22. Ranking of Global Top CRISPR and CRISPR-Associated (Cas) Genes Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players CRISPR and CRISPR-Associated (Cas) Genes Product Solution and Service
Table 26. Date of Enter into CRISPR and CRISPR-Associated (Cas) Genes Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2016-2021) (US$ Million)
Table 29. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2016-2021)
Table 30. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2016-2021)
Table 34. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2016-2021) (US$ Million)
Table 37. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2016-2021) (US$ Million)
Table 39. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2022-2027) & (US$ Million)
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product
Table 69. Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Editas Medicine Company Details
Table 72. Editas Medicine Business Overview
Table 73. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product
Table 74. Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021) & (US$ Million)
Table 75. Editas Medicine Recent Development
Table 76. Caribou Biosciences Company Details
Table 77. Caribou Biosciences Business Overview
Table 78. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 79. Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021) & (US$ Million)
Table 80. Caribou Biosciences Recent Development
Table 81. CRISPR therapeutics Company Details
Table 82. CRISPR therapeutics Business Overview
Table 83. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product
Table 84. CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021) & (US$ Million)
Table 85. CRISPR therapeutics Recent Development
Table 86. Intellia therapeutics, Inc. Company Details
Table 87. Intellia therapeutics, Inc. Business Overview
Table 88. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
Table 89. Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021) & (US$ Million)
Table 90. Intellia therapeutics, Inc. Recent Development
Table 91. Cellectis Company Details
Table 92. Cellectis Business Overview
Table 93. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product
Table 94. Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021) & (US$ Million)
Table 95. Cellectis Recent Development
Table 96. Horizon Discovery Plc Company Details
Table 97. Horizon Discovery Plc Business Overview
Table 98. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product
Table 99. Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021) & (US$ Million)
Table 100. Horizon Discovery Plc Recent Development
Table 101. Sigma Aldrich Company Details
Table 102. Sigma Aldrich Business Overview
Table 103. Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021) & (US$ Million)
Table 104. Sigma Aldrich Recent Development
Table 105. Precision Biosciences Company Details
Table 106. Precision Biosciences Business Overview
Table 107. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 108. Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021) & (US$ Million)
Table 109. Precision Biosciences Recent Development
Table 110. Genscript Company Details
Table 111. Genscript Business Overview
Table 112. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product
Table 113. Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021) & (US$ Million)
Table 114. Genscript Recent Development
Table 115. Sangamo Biosciences Inc. Company Details
Table 116. Sangamo Biosciences Inc. Business Overview
Table 117. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
Table 118. Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021) & (US$ Million)
Table 119. Sangamo Biosciences Inc. Recent Development
Table 120. Lonza Group Limited Company Details
Table 121. Lonza Group Limited Business Overview
Table 122. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product
Table 123. Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021) & (US$ Million)
Table 124. Lonza Group Limited Recent Development
Table 125. Integrated DNA Technologies Company Details
Table 126. Integrated DNA Technologies Business Overview
Table 127. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
Table 128. Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021) & (US$ Million)
Table 129. Integrated DNA Technologies Recent Development
Table 130. New England Biolabs Company Details
Table 131. New England Biolabs Business Overview
Table 132. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product
Table 133. New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021) & (US$ Million)
Table 134. New England Biolabs Recent Development
Table 135. Origene Technologies Company Details
Table 136. Origene Technologies Business Overview
Table 137. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
Table 138. Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021) & (US$ Million)
Table 139. Origene Technologies Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type: 2020 VS 2027
Figure 2. Genome Editing Features
Figure 3. Genetic engineering Features
Figure 4. gRNA Database/Gene Librar Features
Figure 5. CRISPR Plasmid Features
Figure 6. Human Stem Cells Features
Figure 7. Genetically Modified Organisms/Crops Features
Figure 8. Cell Line Engineering Features
Figure 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application: 2020 VS 2027
Figure 10. Biotechnology Companies Case Studies
Figure 11. Pharmaceutical Companies Case Studies
Figure 12. Academic Institutes Case Studies
Figure 13. Research and Development Institutes Case Studies
Figure 14. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered
Figure 15. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Regions: 2020 VS 2027
Figure 18. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Regions (2022-2027)
Figure 19. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players in 2020
Figure 20. Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2020
Figure 21. The Top 10 and 5 Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2020
Figure 22. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2016-2021)
Figure 23. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2022-2027)
Figure 24. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2016-2027)
Figure 26. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2016-2027)
Figure 27. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2016-2027)
Figure 28. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2016-2027)
Figure 32. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2016-2027)
Figure 33. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2016-2027)
Figure 34. Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2016-2027)
Figure 42. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2016-2027)
Figure 43. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2016-2027)
Figure 44. China CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2016-2027)
Figure 52. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2016-2027)
Figure 53. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2016-2027)
Figure 54. Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2016-2027)
Figure 58. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2016-2027)
Figure 59. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2016-2027)
Figure 60. Turkey CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Thermo Fisher Scientific Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
Figure 64. Editas Medicine Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
Figure 65. Caribou Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
Figure 66. CRISPR therapeutics Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
Figure 67. Intellia therapeutics, Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
Figure 68. Cellectis Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
Figure 69. Horizon Discovery Plc Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
Figure 70. Sigma Aldrich Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
Figure 71. Precision Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
Figure 72. Genscript Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
Figure 73. Sangamo Biosciences Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
Figure 74. Lonza Group Limited Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
Figure 75. Integrated DNA Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
Figure 76. New England Biolabs Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
Figure 77. Origene Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Industry Market Size
